Resources

Considerations for development of a platform lentivirus harvest clarification process for cell and gene therapy

New therapies, medicines and cutting-edge technologies have enabled the production of next generation treatments that improve patient care, simplify administration and increase the availability of life changing medicines.  One of the new technologies emerging in the biotech manufacturing market is the use of viral vectors for cell and gene therapy.  One commonly used viral vector …Read More >

Resource Type: Poster
Resource Topic: Clinical & Commercial Manufacturing

VIEW

3 business challenges from the CDMO’s perspective

Felix Hsu, SVP and Global Head of WuXi Advanced Therapies and Erin Harris, Editor in Chief for Cell & Gene had a great conversation around the CDMOs perspective on manufacturing. Click to learn more about 3 Business Challenges from the CDMO’s Perspective. By Erin Harris, Editor-in-Chief of cellandgene.com Copyright © 1996-2019 VertMarkets, Inc. All Rights Reserved.

Resource Type: Publication
Resource Topic: Clinical & Commercial Manufacturing

VIEW

Driving growth of the cell and gene therapy sector

Published in pharma’s almanac – a Nice Insight Magazine Q1 2019 Vol. 5 Number 1 Driving Growth of The Cell and Gene Therapy Sector By Felix Hsu, SVP and Global Head of WuXi Advanced Therapies Abstract: The Senior Vice President and Global Head of WuXi AppTec’s Advanced Therapies business Felix Hsu recently sat down with …Read More >

Resource Type: Article
Resource Topic: Clinical & Commercial Manufacturing

VIEW

Refining platforms for accelerated viral vector production and release

Presentation on Refining Platforms for Accelerated Viral Vector Production and Release, by John Hughes, PhD. Speaks to our journey as a company at WuXi, and how we strive to accelerate progress and time to market. Outlines our platform components and advantages, as well as illustrating our particular technologies & services through a few case studies. …Read More >

Resource Type: Presentation
Resource Topic: Advanced Testing

VIEW

Cell line authentication: Species identity and purity analysis using next generation sequencing

December 2017 Cell Line Authentication: Species Identity and Purity Analysis Using Next Generation Sequencing Christine Mitchell, Scientific Fellow, Technical Development Group Cell Line Authentication assays using Targeted Next Generation Sequencing methods Cell Line Identity – Method overview Qualification of the Cell Line Identity Method Cell Line Purity – analyze for presence of 19 potentially contaminating …Read More >

Resource Type: Presentation
Resource Topic: Advanced Testing

VIEW